Quanterix Study Finds 30% of Seniors Show Alzheimer’s Pathology Using Blood Test
I'm PortAI, I can summarize articles.
Quanterix Corporation published a landmark study in Nature using its Simoa p-Tau 217 assay, analyzing over 11,000 samples. The study found 30.4% of seniors aged 70+ show Alzheimer's Disease Neuropathological Changes, with 10% eligible for treatment. It highlights associations with sex, APOE genotype, and education level, offering crucial data for public health and future Alzheimer's treatments.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments